AlloVir, Inc. (ALVR)
NASDAQ: ALVR · Real-Time Price · USD
0.930
+0.044 (4.97%)
Oct 31, 2024, 4:00 PM EDT - Market closed
AlloVir Market Cap
AlloVir has a market cap or net worth of $106.13 million as of October 31, 2024. Its market cap has decreased by -44.84% in one year.
Market Cap
106.13M
Enterprise Value
-19.50M
1-Year Change
-44.84%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since July 30, 2020, AlloVir's market cap has decreased from $1.55B to $106.13M, a decrease of -93.17%. That is a compound annual growth rate of -46.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2024 | 102.20M | 31.70% |
| Dec 29, 2023 | 77.60M | -83.76% |
| Dec 30, 2022 | 477.90M | -43.30% |
| Dec 31, 2021 | 842.90M | -66.32% |
| Dec 31, 2020 | 2.50B | 61.14% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FibroBiologics | 99.43M |
| FONAR | 99.36M |
| Genenta Science | 98.77M |
| MDxHealth | 98.36M |
| Regulus Therapeutics | 98.20M |
| I-Mab | 96.91M |
| Milestone Pharmaceuticals | 95.96M |
| bluebird bio | 95.91M |